DUBLIN, March 12, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/4z477x/prefilled) have announced the addition of the "Concise Analysis of the International Prefilled Syringes Market - Forecasts to 2019" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Parenteral is the second most applied route of drug administration, after oral. A steady increase in the number of parenteral drugs hasled to rise indemand for various advanced drug delivery devices that ensure ease of administration as well as cost containment. Prefilled syringes constitute one of the fastest growing segments of the injectable drug delivery devices market. The various advantages associated with prefilled syringes over conventional delivery systems, such as vials and ampoules, have been the primary foundation for their success to date and are expected to continue to drive market growth during the forecast period 2013 to 2019. These advantages include ease of administration, improved safety, reduced risk of contamination and accurate dosing.
Depending on the type of material used to manufacture the syringe barrel, prefilled syringes are available mainly in two types, glass prefilled syringes and plastic (polymer) prefilled syringes. Although the industry is witnessing increasing use of polymer by many manufacturers for syringe manufacturing, glass isstill considered as the gold standard and will continue to lead the market in terms of revenue as well as volume. This is attributed to the fact that changing the perception of manufacturers as well as healthcare practitioners from glass to plastic will be a gradual process. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019.
Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Prefilled Syringes Market Overview
Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019
Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019
Chapter 6 Competitive Landscape
Chapter 7 Recommendations
Chapter 8 Company Profiles
- Baxter International, Inc
- Becton, Dickinson & Company
- Gerresheimer AG
- Nipro Corporation
- Schott AG
- Stevanato Group
- Unilife Corporation
- Vetter Pharma International GmbH
- West Pharmaceutical Services, Inc
- Ypsomed Holding AG
For more information visit http://www.researchandmarkets.com/research/4z477x/prefilled
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets